Wai Yuen Tong Medicine (00897) said its profit attributable to owners of the parent for the six months ended 30 September 2014 dropped 80.6% year-on-year to HK$11.49 million.
Its basic and diluted earnings per share were HK0.38 cents.
The revenue from continuing operations amounted to HK$381 million, a decrease of 7.3% from a year earlier.
Such decline in net profit was mainly attributable to, among other things, the decrease in gross profit resulting from the decrease in the Group's turnover and the loss on deemed partial disposal of equity interests in an associate, despite the gain from change in fair value of investments held-for-trading.
No interim dividend will be distributed.